Chataigner H, Onimus M, Polette A
Service de Chirurgie des Scolioses et Orthopédie Infantile, Hôpital Saint-Jacques, Besançon.
Rev Chir Orthop Reparatrice Appar Mot. 1998 Jul;84(4):311-8.
Myeloma represents as much as 40 per cent of malignant primary spine tumors. The aim of this study was to discuss the indications for surgical treatment of spinal myeloma.
18 patients presenting spinal localization of myeloma were operated on. There were 10 males and 8 females. Mean age was 59.9 (41-86). Pain was present in all patients. Seven patients presented neurologic signs: Frankel B: 1 case, Frankel C: 3 cases, Frankel D: 3 cases. Surgical treatment included anterior approach in 6 cases, posterior approach in 5 cases and combined approach in 7 cases. Postoperative medical treatment (chemotherapy, radiotherapy, immunotherapy) was performed in all cases.
Diagnosis was made after surgery in 10 patients on histological findings. There were 13 myelomas and 5 plasmacytomas. Decrease of pain was observed in all cases at first postoperative month; 9 patients were pain free at the 6th postoperative month. Complications occurred in 4 cases: 2 local infections after radiotherapy; mobilisation of an anterior implant in one case and local recurrence in one case requiring secondary surgery. Nine patients were alive at review with a mean follow-up of 57 months. Nine patients were dead with a mean follow-up of 15.4 months. Preoperative Karnofsky score was 50 per cent; Karnofsky score was 77 per cent at follow-up. Neurologic deficit improved in 5 out of 7 cases.
Primary treatment of myeloma is medical associating chemotherapy, corticotherapy, radiotherapy and immunotherapy. Plasmocytoma is frequently revealed by neurologic deficit. Staging of myeloma gives the prognostic. Surgical treatment must be performed when pain is not controlled by medical treatment or when neurologic deficit is present.
Surgery allows rapid and durable functional recovery in patients with spinal myeloma; surgery should be associated to additional medical treatment, unlike spinal metastasis.
骨髓瘤占原发性脊柱恶性肿瘤的比例高达40%。本研究旨在探讨脊柱骨髓瘤的手术治疗指征。
对18例出现脊柱骨髓瘤定位的患者进行了手术。其中男性10例,女性8例。平均年龄为59.9岁(41 - 86岁)。所有患者均有疼痛症状。7例患者出现神经体征:Frankel B级:1例,Frankel C级:3例,Frankel D级:3例。手术治疗包括前路手术6例,后路手术5例,联合手术7例。所有病例术后均进行了药物治疗(化疗、放疗、免疫治疗)。
10例患者术后经组织学检查确诊。其中有13例骨髓瘤和5例浆细胞瘤。术后第一个月所有病例疼痛均有减轻;术后第6个月9例患者疼痛消失。发生并发症4例:放疗后2例局部感染;1例前路植入物松动,1例局部复发需二次手术。9例患者复查时存活,平均随访57个月。9例患者死亡,平均随访15.4个月。术前卡诺夫斯基评分50%;随访时卡诺夫斯基评分77%。7例神经功能缺损患者中有5例得到改善。
骨髓瘤的主要治疗方法是联合化疗、皮质激素治疗、放疗和免疫治疗。浆细胞瘤常表现为神经功能缺损。骨髓瘤的分期可判断预后。当药物治疗无法控制疼痛或出现神经功能缺损时,必须进行手术治疗。
手术可使脊柱骨髓瘤患者快速且持久地恢复功能;与脊柱转移瘤不同,手术应与其他药物治疗相结合。